News

PATH/Matthew Dakin
GHTC op-ed featured in The Hill

A commentary piece authored by GHTC Director Jamie Bay Nishi on the steady and substantial funding necessary to drive breakthrough innovations for global health threats was featured in The Hill

View

PATH/Wendy Stone
GHTC Director quoted in The Hill on Ebola vaccine development

The Hill quoted GHTC Director Jamie Bay Nishi in an article on Ebola vaccine development. 

View

PATH/Wendy Stone
GHTC Director quoted in The Verge on product development for emerging and infectious diseases

The Verge quoted GHTC Director Jamie Bay Nishi in an article on developing drugs and products amidst an outbreak.

View

PATH/Katrina Peach
GHTC Director quoted in CIDRAP on FDA approval of a new drug for highly resistant tuberculosis

CIDRAP quoted GHTC Director Jamie Bay Nishi in an article on the FDA approval of a new drug to treat highly resistant tuberculosis.

View

PATH/Nguyen Ba Quang
GHTC Director quoted in the Los Angeles Times on FDA approval of a new drug for highly drug-resistant tuberculosis

The Los Angeles Times quoted GHTC Director Jamie Bay Nishi in an article on the FDA approval of a new drug to treat highly resistant tuberculosis.

View

Flickr: Diego Gurgel / Secom
Healio Infectious Disease News quotes GHTC Director on pandemic preparedness legislation

Healio Infectious Disease News quoted GHTC Director Jamie Bay Nishi in an article on the signing into law of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act.

View

PATH/Rocky Prajapati
The European Sting crossposts GHTC commentary on UHC

The European Sting reposted a commentary piece co-authored by GHTC Director Jamie Bay Nishi, first published in World Economic Forum's Agenda, on the importance of public-private partnerships and innovation to achieving universal health coverage (UHC).

View

PATH/Eric Becker
WEF features GHTC commentary on the role of innovation in achieving UHC

World Economic Forum's Agenda featured a commentary piece co-authored by GHTC Director Jamie Bay Nishi that makes the case for why public-private partnerships and investments in health innovation are critical to achieving and financing universal health coverage.

View

PATH/Satvir Malhotra
BioCentury quotes GHTC director on emergency preparedness bill

BioCentury quoted GHTC's Director Jamie Bay Nishi in an article discussing the passage by Congress of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act.

View

PATH/Lynn Heinisch
GHTC director quoted in Infectious Disease News article on preparedness legislation

GHTC's Director Jamie Bay Nishi was quoted in an article by Infectious Disease News on passage by the US Congress of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act.

View

Michael Temchine, courtesy of the American Society of Tropical Medicine and Hygiene
Health Policy Watch quotes GHTC director on preparedness legislation

Health Policy Watch quoted GHTC's Director Jamie Bay Nishi in an article discussing the passage by Congress of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act.

View

United States Mission Geneva
GHTC director quoted in Global Health Now article highlighting issues to watch at WHA

GHTC Director Jamie Bay Nishi was quoted in a Global Health Now article previewing the issues to watch at the 72nd World Health Assembly.

View

PATH/Gabe Bienczycki
GHTC commentary featured in Global Health Now

A commentary piece co-authored by GHTC’s US policy and advocacy officer on the prospects for global health funding in the fiscal year 2020 budget was featured in Global Health Now.

View

PATH/Gabe Bienczycki
GHTC report cited in Global Health Now

Data from GHTC's report Return on Innovation: Why global health R&D is a smart investment for the United States was cited in an opinion piece by the Fogarty International Center's Director, Dr. Roger Glass, in the May/June issue of the center's Global Health Matters newsletter.

View

All News

Announcements

Breakthroughs Blog

GHTC in the Media

Advocacy Actions

Our members work to improve health worldwide